Ursodeoxycholic Acid Inhibits Inflammatory Cytokine Expression in THP-1 Cells Infected with Aggregatibacter actinomycetemcomitans |
Song, YuRi
(Department of Oral Microbiology, School of Dentistry, Pusan National University)
Kim, SeYeon (Department of Oral Microbiology, School of Dentistry, Pusan National University) Park, Mee Hee (Department of Oral Microbiology, School of Dentistry, Pusan National University) Na, Hee Sam (Department of Oral Microbiology, School of Dentistry, Pusan National University) Chung, Jin (Department of Oral Microbiology, School of Dentistry, Pusan National University) |
1 | Prakasam, A., S.S. Elavarasu, and R.K. Natarajan, Antibiotics in the management of aggressive periodontitis. J Pharm Bioallied Sci, 2012;4:S252-5 doi:http://dx.doi.org/10.1902/jop.2005.76.2.289. DOI |
2 | Gajardo, M., et al., Prevalence of periodontopathic bacteria in aggressive periodontitis patients in a Chilean population. J Periodontol, 2005;76(2):289-94 doi:http://dx.doi.org/ 10.1902/jop.2005.76.2.289. DOI |
3 | Slots, J. and M. Ting, Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000, 1999;20:82-121. DOI |
4 | Johansson, A., Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response. Toxins (Basel), 2011;3(3): 242-59. doi:http://dx.doi.org/10.3390/toxins3030242. DOI |
5 | Gursoy, U.K., Periodontal bacteria and epithelial cell interactions: role of bacterial proteins. Eur J Dent, 2008;2(4):231-2. |
6 | Tribble, G.D. and R.J. Lamont, Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontol 2000, 2010;52(1):68-83. DOI |
7 | Park, E., et al., Activation of NLRP3 and AIM2 inflammasomes by Porphyromonas gingivalis infection. Infect Immun, 2014;82(1):112-23. DOI |
8 | Li, Y., et al., D(-)-Salicin inhibits the LPS-induced inflammation in RAW264.7 cells and mouse models. Int Immunopharmacol, 2015;26(2):286-94. doi:http://dx.doi.org/10.1016/j.intimp.2015.04.016 DOI |
9 | Tint, G.S., et al., Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones. Ann Intern Med, 1982;97(3):351-6. DOI |
10 | Joo, S.S., et al., Ursodeoxycholic acid inhibits pro-inflammatory repertoires, IL-1 beta and nitric oxide in rat microglia. Arch Pharm Res, 2006;26(12):1067-73. DOI |
11 | Hajishengallis, G., Immune evasion strategies of Porphyromonas gingivalis. J Oral Biosci, 2011;53(3)233-240. |
12 | Kononen, E. and H.P. Muller, Microbiology of aggressive periodontitis. Periodontol 2000, 2014;65(1):46-78. DOI |
13 | Kelk, P., et al., Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun, 2005;73(1):453-8. DOI |
14 | Shenker, B.J., et al., Aggregatibacter actinomycetemcomitans cytolethal distending toxin activates the NLRP3 inflammasome in human macrophages, leading to the release of proinflammatory cytokines. Infect Immun, 2015;83(4): 1487-96. doi:http://dx.doi.org/ 10.1128/IAI.03132-14. DOI |
15 | Cekici, A., et al., Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000, 2014;64(1):57-80. doi:http://dx.doi.org/10.1111/prd.12002. DOI |
16 | Dutzan, N., et al., Interleukin-21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients. J Periodontol, 2012;83(7):948-54. DOI |
17 | Arun, K.V., A. Talwar, and T.S. Kumar, T-helper cells in the etiopathogenesis of periodontal disease: A mini review. J Indian Soc Periodontol, 2011;15(1):4-10. doi:http://dx.doi.org/10.4103/0972-124x.82255 DOI |
18 | Zacarias, J.M., et al., The Influence of Interleukin 17A and IL17F Polymorphisms on Chronic Periodontitis Disease in Brazilian Patients. Mediators Inflamm, 2015;2015:147056. |
19 | Takahashi, K., et al., The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol, 2005;32(4):369-74. DOI |
20 | Park, S.-H., A Short-Term Study of the Effects of UDCA on Gingival Inflammation in the Beagle Dog. J Korean Acad Periodontol, 1999;1-14. |
21 | Sombetzki, M., et al., 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis. J Hepatol, 2015; 62(4):871-8. doi: http://dx.doi.org/10.1016/j.jhep.2014.11.020. DOI |
22 | Nguyen, L., et al., Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res, 1991;10(1-2):15-21. |
23 | Pang, L., et al., Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases. Nutrients, 2015;7(5):3200-18. doi:http://dx.doi.org/10.3390/nu7053200. DOI |